Aquis Stock Exchange Weekly Highlights 19/08/24

Samarkand Group plc announced its full year results for the year ended 31 March 2024. The Company reported total revenue of £16.9m and the gross margin increased from 55% to 60%.

David Hampstead, CEO, said: “I am pleased with the progress being made in shifting the business towards profitability and in defining the future direction of the Group as a scale up platform for high potential, meaningfully different, health and healing brands, anchored in fast growing consumer segments, with the ability to introduce those brands to the Chinese consumer.” Read more

Valereum PLC announced that the Company is using Fireblocks' enterprise-grade technology as a key part of its Real-World Asset infrastructure. Fireblocks will be used for various functions, including delivering a secure infrastructure for sending, storing, and issuing digital assets. Read more

ProBiotix Health PLC announced a new commercial partnership agreement with DanCare Health for InstaMelt; a newly developed food supplement format that offers innovative features for health brands and retailers. It will be sold as a turnkey, direct dose stick solution that melts instantly on the tongue and will be available in China.

Steen Andersen, CEO, commented: "DanCare is well-recognised in the Chinese market as a high-quality innovative brand. With cardiovascular disease on the rise and almost 155 million Chinese adults estimated to have elevated cholesterol levels, there is an increasing consumer focus on cardiometabolic health. With our product offering and cooperation with a market leader like DanCare we are well positioned to tap into this lucrative market over the years to come." Read more